Patrick Wilton

5.3k total citations
92 papers, 4.1k citations indexed

About

Patrick Wilton is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Patrick Wilton has authored 92 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Molecular Biology and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Patrick Wilton's work include Growth Hormone and Insulin-like Growth Factors (62 papers), Pituitary Gland Disorders and Treatments (21 papers) and Sexual Differentiation and Disorders (15 papers). Patrick Wilton is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (62 papers), Pituitary Gland Disorders and Treatments (21 papers) and Sexual Differentiation and Disorders (15 papers). Patrick Wilton collaborates with scholars based in Sweden, United Kingdom and United States. Patrick Wilton's co-authors include Michael B. Ranke, Kerstin Albertsson‐Wikland, Pierre Chatelain, Anders Lindberg, Roger Abs, Wayne S. Cutfield, John P. Monson, David A. Price, Ulla Feldt‐Rasmussen and Feyza Darendelıler and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Kidney International.

In The Last Decade

Patrick Wilton

90 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Patrick Wilton 3.1k 1.2k 1.1k 1.0k 720 92 4.1k
Mariacarolina Salerno 2.4k 0.8× 541 0.4× 945 0.8× 1.0k 1.0× 238 0.3× 160 3.7k
S Shalet 1.5k 0.5× 747 0.6× 539 0.5× 338 0.3× 287 0.4× 53 2.9k
José Timsit 1.4k 0.4× 358 0.3× 1.2k 1.0× 1.8k 1.7× 258 0.4× 136 4.1k
Adda Grimberg 1.8k 0.6× 550 0.5× 1.1k 1.0× 505 0.5× 290 0.4× 85 3.0k
Päivi Tapanainen 799 0.3× 671 0.6× 484 0.4× 276 0.3× 224 0.3× 52 2.1k
R. Coutant 1.1k 0.3× 491 0.4× 677 0.6× 812 0.8× 111 0.2× 119 2.3k
Thomas P. Foley 1.6k 0.5× 498 0.4× 655 0.6× 502 0.5× 86 0.1× 85 2.8k
Małgorzata Waśniewska 1.8k 0.6× 387 0.3× 839 0.7× 965 1.0× 142 0.2× 204 3.5k
B.‐Å. Bengtsson 2.6k 0.8× 368 0.3× 603 0.5× 422 0.4× 797 1.1× 42 3.4k
Claire Nihoul‐Feketé 2.3k 0.7× 445 0.4× 2.2k 1.9× 1.5k 1.5× 131 0.2× 121 6.3k

Countries citing papers authored by Patrick Wilton

Since Specialization
Citations

This map shows the geographic impact of Patrick Wilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Wilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Wilton more than expected).

Fields of papers citing papers by Patrick Wilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Wilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Wilton. The network helps show where Patrick Wilton may publish in the future.

Co-authorship network of co-authors of Patrick Wilton

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Wilton. A scholar is included among the top collaborators of Patrick Wilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Wilton. Patrick Wilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Fred R.T., et al.. (2013). An oral preparation containing hylauronic acid (ORALVISC®) can reduce osteoarthritis knee pain and serum and synovial fluid bradykinin. Osteoarthritis and Cartilage. 21. S150–S150. 2 indexed citations
2.
Fideleff, Hugo, Björn Jonsson, Maria Kołtowska‐Häggström, et al.. (2011). GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients. Journal of Pediatric Endocrinology and Metabolism. 25(1-2). 97–105. 11 indexed citations
3.
Boguszewski, Margaret Cristina da Silva, et al.. (2011). Short Children Born Prematurely: Data from KIGS. Hormone Research in Paediatrics. 76(Suppl. 1). 39–41. 1 indexed citations
4.
Mattsson, Anders, et al.. (2008). Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients. 16. 2 indexed citations
5.
Ranke, Michael B., Anders Lindberg, David A. Price, et al.. (2007). Age at Growth Hormone Therapy Start and First-Year Responsiveness to Growth Hormone Are Major Determinants of Height Outcome in Idiopathic Short Stature. Hormone Research in Paediatrics. 68(2). 53–62. 93 indexed citations
6.
Maiter, Dominique, Roger Abs, Gudmundur Johannsson, et al.. (2006). Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database. European Journal of Endocrinology. 155(2). 253–260. 22 indexed citations
7.
Ranke, Michael B., David A. Price, Anders Lindberg, et al.. (2005). Final Height in Children with Medulloblastoma Treated with Growth Hormone. Hormone Research in Paediatrics. 64(1). 28–34. 21 indexed citations
8.
Monson, JP, Roger Abs, Ulla Feldt‐Rasmussen, et al.. (2001). SAFETY AND MORTALITY DURING GROWTH HORMONE (GH) REPLACEMENT THERAPY IN 4457 ADULT GH-DEFICIENT PATIENTS - A KIMS DATABASE ANALYSIS. 1 indexed citations
9.
Ranke, Michael B., Anders Lindberg, Pierre Chatelain, et al.. (2000). Prediction of Long-Term Response to Recombinant Human Growth Hormone in Turner Syndrome: Development and Validation of Mathematical Models. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4212–4218. 115 indexed citations
10.
Bengtsson, B.-Å., et al.. (2000). No increased mortality in growth hormone treated adults Experience from KIMS. 10(3). 166. 1 indexed citations
11.
Monson, John P., Roger Abs, Bengt‐Åke Bengtsson, et al.. (2000). Growth hormone deficiency and replacement in elderly hypopituitary adults. Clinical Endocrinology. 53(3). 281–289. 70 indexed citations
12.
Bengtsson, Bengt‐Åke, Roger Abs, Helge Bennmarker, et al.. (1999). The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. 84(11). 3929–3935. 137 indexed citations
13.
14.
Blum, WF, et al.. (1994). Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Paediatrica. 83(s399). 117–124. 97 indexed citations
15.
Heinrichs, Claudine, H. L. Vis, Pierre Bergmann, Patrick Wilton, & J P Bourguignon. (1993). Effects of 17 months treatment using recombinant insulin‐like growth factor‐I in two children with growth hormone insensitivity (Laron) syndrome. Clinical Endocrinology. 38(6). 647–651. 15 indexed citations
16.
Wilton, Patrick, L. Widlund, Olivier Guilbaud, & Martin Ritzén. (1988). PHARMACOKINETIC PEOFILE OF AN I.V. AND S.C. DOSE OF RECOMBINANT HUMAN GROWTH HORMONE. Pediatric Research. 23(1). 117–117. 2 indexed citations
17.
Wilton, Patrick & R Gunnarsson. (1988). Clinical Experience with Genotropin in Growth Hormone Deficient Children. Acta Paediatrica. 77(s343). 95–101. 15 indexed citations
18.
Gunnarsson, R & Patrick Wilton. (1987). Clinical Experience with Genotropin Worldwide: An Update March 1987. Acta Paediatrica. 76(s337). 147–152. 7 indexed citations
19.
Ka, Kennedy, et al.. (1986). Effect of epidermal growth factor on lung liquid secretion in fetal sheep.. PubMed. 8(6). 421–33. 9 indexed citations
20.
Wilton, Patrick, et al.. (1980). 5-Hydroxytryptamine depletion attenuates hypothermia in rats.. South African Journal of Science. 76(5).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariacarolina Salerno Breakdown of academic impact, for papers by S Shalet Breakdown of academic impact, for papers by José Timsit Breakdown of academic impact, for papers by Adda Grimberg Breakdown of academic impact, for papers by Päivi Tapanainen Breakdown of academic impact, for papers by R. Coutant Breakdown of academic impact, for papers by Thomas P. Foley Breakdown of academic impact, for papers by Małgorzata Waśniewska Breakdown of academic impact, for papers by B.‐Å. Bengtsson Breakdown of academic impact, for papers by Claire Nihoul‐Feketé
Rankless by CCL
2026